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Objectives: Tortuosity increases the challenges of
endovascular aneurysm repair (EVAR). This study assesses
the impact of increasing tortuosity indices on EVAR
outcomes.
Methods: A total of 501 of 1380 patients met inclu-
sion criteria and were analyzed using 3D reconstructions
of computed tomography angiograms. Tortuosity indices
(TI) were calculated, and the impact of increasing tortuos-
ity on endoleaks, reinterventions, and abdominal aortic
aneurysm (AAA)-related and all-cause mortality were
assessed. Hazard ratios (HR) were calculated based on
0.01 incremental increases of TI.
Results: Increased TI of the left common iliac artery
(LCIA) resulted in a 17% increased risk of AAA-related
mortality (P ¼ .001) and a 7% increased risk of all-cause
mortality (Table, P ¼ .02). Increased TI from the lowest
renal artery to the right iliac bifurcation was associated
with a 63% increased risk for AAA-related mortality (P ¼
.01) and a 22% increased risk for all-cause mortality (P ¼
.01). Patients with increased TI from the lowest renal ar-
tery through the LCIA had signiﬁcantly increased risk of
adverse events, including an 83% increased risk for AAA-
related mortality (P ¼ .02), a 20% increased risk for all-
cause mortality (P ¼ .006), an 18% increased risk for the
development of an endoleak (P ¼ .002), and a 27%
increased risk for reintervention (P ¼ .01).
Conclusions: Increased TI is associated with increased
postoperative complications, including endoleaks, reinter-
ventions, and both AAA-related and all-cause mortality af-
ter EVAR. Greater caution is recommended when
performing EVAR in patients with increased TI.
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Total (N ¼ 501) TI: LCIA
Adverse outcome HR (95% CI), P
AAA-related mortality 1.17 (1.06-1.29), .001
All-cause mortality 1.07 (1.01-1.13), .02
Endoleak (any) 0.98 (0.91-1.05), .53
Reintervention 0.98 (0.86-1.12), .76
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Objectives: Recently, patient’s who were subjectively
deemed to be “unﬁt for open aneurysm repair” were eval-
uated and found more likely to have advanced age, cardiac
disease, chronic obstructive pulmonary disease, and larger
aneurysms. The objective of this study was to analyze pa-
tients who underwent open repair with these characteristics
and to determine if they had worse outcomes after surgery;
justifying a designation of “unﬁt.”
Methods: Data on 2320 open aneurysm repairs be-
tween 2003-2013 at 20 Vascular Study Group of New En-
gland centers were used for this study. All aneurysm repairs
were included. Patients were separated into risk factor
groups based on the number of “unﬁt” risk factors they
had. End points included in-hospital major adverse events.
Results: Of 2329 patients, 15.4% had no risk factors,
34.3% had one risk factor, 33.1% had two risk factors,
15.3% had three risk factors, and 2.3% had all four deﬁned
risk factors. Patients with two or more risk factors had
more postoperative cardiac complications, including
myocardial infarction (P ¼ .01), dysrhythmia (P ¼ .003),
and new congestive heart failure (P ¼ .02). They also had
more postoperative renal dysfunction (P ¼ .02), a higher
rate of returning to the operating room (P < .001), bowel
ischemia (P ¼ .04), and higher in-hospital mortality (P ¼
.01). Patients with just one risk factor or higher were found
to have higher rates of respiratory complications (P< .001).
There did not appear to be a signiﬁcant difference between
postoperative wound infection rates (4.01% in the no risk
factor group vs 5.7% in the four risk factor group; P ¼
.31) and incidence of distal limb ischemia (2.0% in the no
risk factor groups vs 5.7% in the four risk factor group, P
¼ .10) among the different risk factor groups.
Conclusions: This study supports that the factors of
advanced age, cardiac disease, chronic obtructive pulmo-
nary disease, and larger aneurysm size can be used to catego-
rize patients as ﬁt vs unﬁt for open repair. Also it shows that
patients with increasing number of “unﬁt” characteristics
tend to have worse outcomes after open aneurysm repair.TI: Lowest renal artery to
RCIA bifurcation LCIA bifurcation
HR (95% CI), P HR (95% CI), P
1.63 (1.12-2.37), .01 1.83 (1.09-3.05), .02
1.22 (1.05-1.42), .01 1.2 (1.05-1.36), .006
1.10 (0.97-1.25), .15 1.18 (1.06-1.30), .002
1.11 (0.87-1.42), .39 1.27 (1.06-1.53), .01
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Objectives: To determine whether renal perfusion
with cold crystalloid solution enriched with histidine-tryp-
tophan-ketoglutarate (Custodiol) provides better protec-
tion against renal ischemic injury than cold lactated
Ringer’s solution in patients undergoing suprarenal aortic
aneurysm (sAAA) open repair.
Methods: We reviewed 256 consecutive patients un-
dergoing sAAA open repair between 1993 and 2013. In
181 cases, direct perfusion of at least one renal artery was
performed. Among these patients, 87 had cold renal perfu-
sion with Ringer’s lactate solution and 94 with Custodiol so-
lution. Propensity score matching based on baseline clinical
variables that were expected to inﬂuence renal outcomes was
performed to correct for any bias that may have been asso-
ciated with the use of Custodiol. Postoperative acute renal
dysfunction (ARD) stratiﬁed in ﬁve classes according to
postoperative serum creatinine elevation and need for dial-
ysis was compared in the two groups, and independent pre-
dictors of ARD were identiﬁed at multivariate analysis.
Results: After propensity score matching we were able
to match 74 Custodiol cases one-to-one to those receiving
perfusion with lactated Ringer’s solution. Overall 30-day
mortality was 3.4%, temporary hemodialysis or continuous
venovenous hemoﬁltration was 4.7%, and dialysis at
discharge was 2.7%. Freedom from ARD >2 (>100%
elevation in baseline ceratinine level) and from the need
for dialysis were signiﬁcantly increased in the Custodiol
group (P ¼ .007 and P ¼ .04, respectively). At multivariate
analysis, Custodiol perfusion and clamping time were the
independent predictors of non-ARD >2.
Conclusions: In this series of sAAA repair, perfusion
with (4C) Custodiol offered superior renal protection
when compared with (4C) Ringer’s lactate. Larger series
and/or randomized trials are needed to conﬁrm this ﬁnding.
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Objectives: To evaluate the level of endoleak and the
decrease in size of infrarenal abdominal aortic aneurysm
(AAA) after coil embolization during endovascular aneu-
rysm repair (EVAR) for patients at risk for type II
endoleak.
Methods: Between 2009 and 2013, 80 patients with
AAA and a high risk for type II endoleak were treated
with coil embolization of the aneurysm sac during EVAR.
Embolization was performed using a microcatheter placed
between the stentgraft and the aortic aneurysm wall.
Follow-up using computed tomography (CT) scans (ﬁrst
month, 6 months, 1 year, and 1 years) was obtained to eval-
uate presence of endoleaks and the size of the aneurysm sac.
Results: The mean number of coils used for emboliza-
tion was 11 (range, 8-14 coils). Technical success was achieved
in all patients. Only one of 80 patients (1.2%) presented a type
II endoleak on follow-up CT scans. Statistical analysis (paired
t-test) showed a signiﬁcant decrease of the aneurysm diameter
at 6 months (P ¼ .036), 1 year (P ¼ .004), and 2 years (P ¼
.001). The mean follow-up period after treatment was 13
months (range, 1-29 months). There were no procedure-
related complications and two secondary interventions.
Conclusions: Coil embolization of the aneurysm
sac during EVAR for patients at risk for type II endo-
leak is technically feasible and clinically effective in pre-
venting type II endoleak. This led to a rapid decrease in
size of AAA and low level of secondary intervention.
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